Navigation Links
Pharmasset Reports Fiscal First Quarter 2009 Financial Results
Date:2/9/2009

PHARMASSET, INC. CONDENSED BALANCE SHEET (UNAUDITED) As of December 31, As of 2008 September 30, (unaudited) 2008 ----------- ---- ASSETS CURRENT ASSETS: Cash and cash equivalents $51,315,887 $63,073,103 Short-term investments 498,467 497,310 Amounts due from collaboration partner 906,072 1,169,690 Prepaid expenses and other assets 641,465 1,008,083 ------- --------- Total current assets 53,361,891 65,748,186 ---------- ---------- EQUIPMENT AND LEASEHOLD IMPROVEMENTS: Laboratory, office furniture and equipment 3,541,633 3,362,846 Leasehold improvements 1,836,553 1,836,553 --------- --------- 5,378,186 5,199,399 Less accumulated depreciation and amortization (2,681,396) (2,432,325) ---------- ---------- Total equipment and leasehold improvements, net 2,696,790 2,767,074 OTHER ASSETS 456,377 466,809 ------- ------- TOTAL $56,515,058 $68,982,069 =
'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock
2. Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients
3. Pharmasset to Present at Two Upcoming Investor Conferences
4. Pharmasset to Present at the Natixis Bleichroeder Hidden Gems Conference on Monday, October 13th
5. Pharmasset to Present at the JMP Securities Healthcare Focus Conference on Monday, October 6th
6. Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders
7. Pharmasset to Present at the Upcoming Citibank and Morgan Stanley Investor Conferences
8. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
9. Pharmasset Announces $25.9 Million Registered Direct Offering of Common Stock
10. Pharmasset Joins Russell 3000 Index
11. Pharmasset to Present at the Needham & Co. Biotechnology and Medical Technology Conference on Wednesday, June 11th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sept. 2, 2015 Axovant Sciences Ltd. (NYSE: ... of dementia, today announced upcoming presentations at three investor conferences: ... the Baird 2015 Healthcare Conference in New York ... Thursday, September 10 at 2:00 PM at the BioCentury NewsMakers ... Millennium Broadway Hotel & Conference Center , Thursday, September ...
(Date:9/2/2015)... ... September 02, 2015 , ... The wet form of macular ... anti-vascular endothelial growth factor agents given by injection into the eye. Dry macular ... scientific protocol for the many millions diagnosed with it. AMD usually starts in ...
(Date:9/2/2015)... ... September 02, 2015 , ... Drug companies increasingly ... BCC Research reveals in its new report that the U.S. will generate ... category and generates the most market demand. , BCC Research examines plant-derived ...
(Date:9/2/2015)... TEL-AVIV, Israel , September 2, 2015 /PRNewswire/ ... BLGTY, TASE: BOLT) ("BioLight" or the "Company"), a ... innovations in ophthalmology and cancer diagnostics, announced today ... treatment of glaucoma will be delivered at the ... of the European Society of Cataract & Refractive ...
Breaking Biology Technology:Axovant Sciences To Present At Upcoming Investor Conferences 2Axovant Sciences To Present At Upcoming Investor Conferences 3StemCell GeneticMed Announces That It Has Started Stem Cell Treatments for Age Related Dry Macular Degeneration (AMG) 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 3Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3
... Sept. 30 From November 19 - 22,2008, ... 40th,International Trade Fair with Congress - World Forum ... the medical industry, MEDICA 2008 will,feature about 4,300 ... special events., Exhibit categories at MEDICA 2008 ...
... study shows quota-based plans most popular among ... device and technology products, EVANSTON, Ill., ... Research (IPR) study, conducted by global sales ... ), finds that an,increasing number of companies ...
... (Nasdaq: VRNM ), a pioneer in the ... announced today,that Janet Roemer, Executive Vice President and ... upcoming William Blair & Company 2008,Small-Cap Growth Stock ... a.m. ET on Tuesday, October 7, 2008 and ...
Cached Biology Technology:MEDICA 2008 Returns in November 2Quota-Based Compensation Plans Outpace Ranking Plans 2Quota-Based Compensation Plans Outpace Ranking Plans 3Verenium Corporation to Present at the William Blair & Company 2008 Small-Cap Growth Stock Conference 2Verenium Corporation to Present at the William Blair & Company 2008 Small-Cap Growth Stock Conference 3
(Date:9/1/2015)... VIEW, Calif. , Sept. 1, 2015 /PRNewswire/ ... with travelers during airport passenger screening. This is ... the passenger screening process will become unintrusive. An ... pre-clearance based on voluntary background investigations will transform ... from Frost & Sullivan, Global Airport Passenger ...
(Date:8/28/2015)... India , August 28, 2015 ... Assessment and Training Market by Assessment Type (Pen & ... Learning, Brain Training, Corporate Learning, Academic Research), Vertical and ... Cognitive Assessment and Training Market to grow from USD ... 2020, at a Compound Annual Growth Rate (CAGR) of ...
(Date:8/24/2015)... , August 24, 2015 The ... ,s largest biometrics manufacturer DERMALOG and its customized solutions ... "2015 African Biometrics Company of the Year Award". DERMALOG is ... Nigeria .   -Cross reference: Picture is ... - On Thursday evening, in ...
Breaking Biology News(10 mins):The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 2The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 3The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 4Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 4Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3
... 2013 /PRNewswire-iReach/ -- Nitro Solution, a website that offers high ... just posted a new article to its website that addresses ... a drug called Amlodipine. (Photo: http://photos.prnewswire.com/prnh/20131111/MN13653 ) ... drug, which is sold under the name of Norvasc, had ...
... 11, 2013 New data suggest that the ... injury. Researchers determined that alcohol given to mice ... human alcoholic hepatitis. Further they found that although ... FOXO3, in combination they suppressed FOXO3, reduced expression ...
... Researchers led by bioengineers at the University of California, San ... E. coli cells and individual neurons from the ... sequencing technique that confines genome amplification to fluid-filled wells with ... is published in the journal Nature Biotechnology on ...
Cached Biology News:Nitric Oxide Supplements Website Nitro Solution Posts New Article about the Benefits of Amlodipine 2Nitric Oxide Supplements Website Nitro Solution Posts New Article about the Benefits of Amlodipine 3Transcription factor may protect against hepatic injury caused by hepatitis C and alcohol 2Transcription factor may protect against hepatic injury caused by hepatitis C and alcohol 3Single-cell genome sequencing gets better 2Single-cell genome sequencing gets better 3
...
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
...
Biology Products: